At a glance
- Originator Kuraray; Morishita Jintan
- Class Antineoplastics; Antiulcers; Retinoids; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 15 May 1996 Discontinued-Preclinical for Cancer in Japan (Unknown route)